1Fittipaldi N, Klopfenstein C, Gottschalk M, et al. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus Pleuropneumoniae from carrier pigs[J]. Can J Vet Res, 2005, 69(2):146-150.
2Nerland E M, LeBlanc J M, Fedwick J P, et al. Effects of oral administration of tilmic-osin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropn-eumoniae[J]. Am J Vet Res, 2005, 66(1) :100-107.
3Modric S, Webb A I, Derendorf H. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle[J]. Journal of Veterinary Pharmacology and Therapeutics, 1998, 21(6) : 444-452.
4Diarra M S, Malouin F, Jacques M. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramyein at subminimal and suprainhibitory concentrations on some swine and ho vine respiratory tract pathogens[J]. International Journal of Antimicrohial Agents, 1999, 12(3) :229-237.
5Binder S, Le N B, Bemer H, et al. The effectiveness of tilmicosin in respiratory diseases of swine [J]. Berliner Munch Tierarztl Woehenschr,1993, 106(1) :6-9.
6Paradis M A, Vessie G H, Merrill J K, et al. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine [J]. Can J Vet Res, 2004, 68(1):7-11.
7Main B W, Means J R, Rinkema L E, et al. Cardiovascular effects of the macrolide antibiotic tilmicosin, administerd alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs [J]. Journal of Veterinary Pharmacology and Therapeutics, 1996, 19 (3):225-32.
8Shen J, Li C, Jiang H, et al. Pharmacokinetics of tilmicosin after oral admini- stration in swine[J]. American Journal of Veterinary Research, 2005, 66(6) : 1071-1074.
9Thompson T D, Laudert S B, Chamberland S, et al. Micotii pharmacokinetics of tilmicosin, a semi-synthetic macrolide antibiotic, in acutely pneumonic cattle and primary alveolar macrophages[R]. UK:Edinburgh, 1994 : 31-32.
